{"filing":{"accession_number":"0000926617-26-000052","cik":"0000926617","ticker":"AWHL","company_name":"Aspira Women's Health Inc.","form":"8-K","filing_date":"2026-07-15","report_date":null,"primary_document":"awhl-20260706x8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/926617/000092661726000052/awhl-20260706x8k.htm"},"events":[{"id":18139,"run_id":16294,"accession_number":"0000926617-26-000052","anchor_item_number":"1.01","event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"Aspira Women's Health Inc. entered into a Subordinated Business Loan and Security Agreement with Agile Lending, LLC on July 6, 2026, creating a new direct financial obligation of $1,050,000 principal, maturing January 26, 2027, with $441,000 in interest charges.","company_name":"Aspira Women's Health Inc.","ticker":"AWHL","filing_date":"2026-07-15","form":"8-K","submitted_at":null,"items":[{"id":16857,"accession_number":"0000926617-26-000052","item_number":"1.01","item_title":"Entry into a Material Definitive Agreement.","event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"The Company entered into a Subordinated Business Loan and Security Agreement with Agile Lending, LLC on July 6, 2026, creating a new direct financial obligation. The secured term loan is evidenced by a Subordinated Secured Promissory Note in the principal amount of $1,050,000, maturing January 26, 2027, with $441,000 in interest charges. This is a material debt issuance disclosed under Item 1.01, distinct from a covenant breach or refinancing of existing obligations.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-15T20:13:40.977111+00:00","company_name":"","ticker":null,"filing_date":""},{"id":16858,"accession_number":"0000926617-26-000052","item_number":"2.03","item_title":"Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.","event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.75,"reasoning":"Item 2.03 explicitly addresses creation of a direct financial obligation. The filing incorporates Item 1.01 by reference, which typically covers material acquisitions, dispositions, or other significant transactions that create financial obligations. The reference to a direct financial obligation in Item 2.03 indicates a debt issuance or similar financial obligation has been created, though the specific details are not provided in this excerpt.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-15T20:13:40.977111+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":16857,"accession_number":"0000926617-26-000052","item_number":"1.01","item_title":"Entry into a Material Definitive Agreement.","event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"The Company entered into a Subordinated Business Loan and Security Agreement with Agile Lending, LLC on July 6, 2026, creating a new direct financial obligation. The secured term loan is evidenced by a Subordinated Secured Promissory Note in the principal amount of $1,050,000, maturing January 26, 2027, with $441,000 in interest charges. This is a material debt issuance disclosed under Item 1.01, distinct from a covenant breach or refinancing of existing obligations.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-15T20:13:40.977111+00:00","company_name":"Aspira Women's Health Inc.","ticker":"AWHL","filing_date":"2026-07-15"},{"id":16858,"accession_number":"0000926617-26-000052","item_number":"2.03","item_title":"Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.","event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.75,"reasoning":"Item 2.03 explicitly addresses creation of a direct financial obligation. The filing incorporates Item 1.01 by reference, which typically covers material acquisitions, dispositions, or other significant transactions that create financial obligations. The reference to a direct financial obligation in Item 2.03 indicates a debt issuance or similar financial obligation has been created, though the specific details are not provided in this excerpt.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-15T20:13:40.977111+00:00","company_name":"Aspira Women's Health Inc.","ticker":"AWHL","filing_date":"2026-07-15"}]}